Objective: Our purpose was to determine the extent to which nausea and vomiting of pregnancy
affects a woman's quality of life (QOL), ability to function, and health care resource use. …

Unlike severe nausea and vomiting of pregnancy (NVP), it is not known whether milder
forms of NVP have been associated with psychosocial morbidity. We undertook the study to …

… doses as high as 100 g/m2 or 60 g/m2, we found a total ifosfamide dose of 45 g/m2 to be …
doses of 45 g/m2 should be carefully considered, especially in children younger than age 3. …

A delayed‐release combination of doxylamine‐pyridoxine (D‐P) (Diclectin®) is the only
approved antiemetic medication for use in pregnancy in Canada. The standard recommended …

Nausea and vomiting of pregnancy is the most common condition in pregnancy and affects
up to 80% of all pregnant women. There are a large number of pharmacological agents that …

The symptomatology of nausea and vomiting of pregnancy (NVP) ranges from mild to very
severe. The most advanced method to measure the burden of NVP, the Rhode’s scores, …

Objectives: To characterize a cohort of pregnant women who required hospital care owing
to nausea and vomiting of pregnancy (NVP) and to identify variables that could serve as …

… Atanackovic G, Navioz Y, Moretti ME, Koren G. The safety of higher than standard dose of
doxylamine-pyridoxine (Diclectin) for nausea and vomiting of pregnancy. J Clin Pharmacol …

… Atanackovic and Koren are with the Motherisk Program and the Division of Clinical
Pharmacology and Toxicology, Department of Pediatrics and Research Institute, The …

… /g of dry weight liver tissue, associated with no evidence of iron-induced toxicity (group A). In
the remaining 12, hepatic iron concentration had either stabilized at higher than 7 mg/g … /g of …